Skip to main content

Advertisement

Log in

Abstract

Fetal supraventricular tachycardia may lead to low cardiac output, nonimmune hydrops and fetal demise. We are presenting an antenatal case in whom fetal SVT was picked up during examination and was confirmed by ultrasound and fetal echocardiography. Following administration of flecainide to mother, fetal SVT improved, baby did not develop hydrops, pregnancy continued till term and patient delivered vaginally. Awareness regarding existence of fetal arrhythmias is important for obstetricians as early diagnosis and treatment before development of fetal hydrops will not only help in improving fetal outcome but also in reducing cesarean section rates in these cases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Ghenbot R, Brown V, Markham K. Management of fetal supraventricular tachycardia: three cases at a Single Institution. Obstet Gynecol Cases Rev. 2019;6:146. https://doi.org/10.23937/2377-9004/1410146.

    Article  Google Scholar 

  2. Bravo- Valenzuela NJ, Rocha LA, Machado Nardozza LM, Junior EA. Fetal cardiac arrhythmias: current evidence. Ann Pediatr Cardiol. 2018;11:148–63.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Malhame I, Gandhi C, Tarabulsi G, Esposito M, Lombardi K, et al. Maternal monitoring and safety considerations during antiarrhythmic treatment for fetal supraventricular tachycardia. Obstet Med. 2019;12(2):66–75.

    Article  PubMed  Google Scholar 

  4. Broom E, Thomas JT, Petersen S, Gooi A, Ward C, et al. Management of fetal supraventricular tachycardia: case series from a tertiary Perinatal Cardiac Center. Fetal Diagn Ther. 2021;48:794–800.

    Article  PubMed  Google Scholar 

Download references

Funding

There was no funding in this case-report.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vineeta Gupta M.S..

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

Ethical approval is not required from Institutional ethics committee for case reports.

Informed Consent

Written informed consent was obtained from the patient mentioned in the case report.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Dr. Vineeta Gupta is a Prof & Head. Dr. Shweta Nimonkar is an Associate Prof. Dr. Swati Kohli is an Junior resident. Dr. Sahil Mahajan is an Associate Prof Dr. Namrata Saxena is a Professor.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gupta, V., Nimonkar, S., Kohli, S. et al. In-Utero Treatment of Fetal SVT: A Case Report. J Obstet Gynecol India (2024). https://doi.org/10.1007/s13224-024-01952-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s13224-024-01952-2

Keywords

Navigation